AU622877B2 - Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract - Google Patents
Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract Download PDFInfo
- Publication number
- AU622877B2 AU622877B2 AU26850/88A AU2685088A AU622877B2 AU 622877 B2 AU622877 B2 AU 622877B2 AU 26850/88 A AU26850/88 A AU 26850/88A AU 2685088 A AU2685088 A AU 2685088A AU 622877 B2 AU622877 B2 AU 622877B2
- Authority
- AU
- Australia
- Prior art keywords
- medicinal
- container
- bladder
- polymeric
- porous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 32
- 210000001635 urinary tract Anatomy 0.000 title claims description 27
- 239000000203 mixture Substances 0.000 title description 15
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 23
- 229960004857 mitomycin Drugs 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 11
- 230000003204 osmotic effect Effects 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229940088710 antibiotic agent Drugs 0.000 claims description 7
- 238000009792 diffusion process Methods 0.000 claims description 7
- -1 polypropylene Polymers 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 239000002246 antineoplastic agent Substances 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 210000002700 urine Anatomy 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 229940035674 anesthetics Drugs 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 4
- 229940064004 antiseptic throat preparations Drugs 0.000 claims description 4
- 239000003193 general anesthetic agent Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 229940121357 antivirals Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 239000002195 soluble material Substances 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 description 43
- 239000003814 drug Substances 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 229930192392 Mitomycin Natural products 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 230000027939 micturition Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229940070891 pyridium Drugs 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/057,298 US4871542A (en) | 1987-04-30 | 1987-04-30 | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2685088A AU2685088A (en) | 1990-08-02 |
| AU622877B2 true AU622877B2 (en) | 1992-04-30 |
Family
ID=22009744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU26850/88A Ceased AU622877B2 (en) | 1987-04-30 | 1988-12-14 | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4871542A (en, 2012) |
| EP (1) | EP0372137A1 (en, 2012) |
| AU (1) | AU622877B2 (en, 2012) |
| IN (1) | IN168149B (en, 2012) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5713888A (en) * | 1990-10-31 | 1998-02-03 | Baxter International, Inc. | Tissue implant systems |
| JP3508023B2 (ja) * | 1990-10-31 | 2004-03-22 | バクスター、インターナショナル、インコーポレイテッド | 密接血管化埋め込み材料 |
| US5282829A (en) * | 1991-08-15 | 1994-02-01 | United States Surgical Corporation | Hollow body implants |
| US5629008A (en) * | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
| US5674850A (en) * | 1993-12-23 | 1997-10-07 | Ferring Ab | High purity desmopressin produced in large single batches |
| EP0670738A1 (en) * | 1993-09-24 | 1995-09-13 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
| US5798119A (en) * | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| CA2285591A1 (en) * | 1997-04-03 | 1998-10-08 | Point Biomedical Corporation | Intravesical drug delivery system |
| US6776792B1 (en) | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
| US6485514B1 (en) * | 1997-12-12 | 2002-11-26 | Supergen, Inc. | Local delivery of therapeutic agents |
| US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| US6293923B1 (en) * | 1999-03-15 | 2001-09-25 | Innoventions, Inc. | Intravesicular balloon |
| US20020165427A1 (en) * | 1999-03-15 | 2002-11-07 | Daniel Yachia | Intravesicular device |
| US6139535A (en) * | 1999-05-27 | 2000-10-31 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
| US6398718B1 (en) | 2000-06-15 | 2002-06-04 | Innoventions, Inc. | Intravesicular device |
| US6783793B1 (en) | 2000-10-26 | 2004-08-31 | Advanced Cardiovascular Systems, Inc. | Selective coating of medical devices |
| US8277868B2 (en) * | 2001-01-05 | 2012-10-02 | Abbott Cardiovascular Systems Inc. | Balloon catheter for delivering therapeutic agents |
| US6544223B1 (en) * | 2001-01-05 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Balloon catheter for delivering therapeutic agents |
| US6565659B1 (en) | 2001-06-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Stent mounting assembly and a method of using the same to coat a stent |
| US8563592B2 (en) | 2001-11-01 | 2013-10-22 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment and methods |
| AU2002350115A1 (en) * | 2001-11-01 | 2003-05-12 | Spectrum Pharmaceuticals, Inc. | Medical compositions for intravesical treatment of bladder cancer |
| US6869436B2 (en) * | 2002-02-07 | 2005-03-22 | Scimed Life Systems, Inc. | Surgical clip with a self-releasing fluid reservoir |
| CA2503193A1 (en) * | 2002-10-22 | 2004-05-06 | The Biomerix Corporation | Method and system for intravesicular delivery of therapeutic agents |
| US7803395B2 (en) | 2003-05-15 | 2010-09-28 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
| US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
| US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
| US7563324B1 (en) | 2003-12-29 | 2009-07-21 | Advanced Cardiovascular Systems Inc. | System and method for coating an implantable medical device |
| US7553377B1 (en) | 2004-04-27 | 2009-06-30 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for electrostatic coating of an abluminal stent surface |
| DE102004028036A1 (de) * | 2004-06-09 | 2006-01-05 | Airbus Deutschland Gmbh | Wasseraufbereitung für Luftfahrzeuge |
| US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
| US8750983B2 (en) | 2004-09-20 | 2014-06-10 | P Tech, Llc | Therapeutic system |
| US7632307B2 (en) | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
| US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
| US7744556B2 (en) | 2005-03-25 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Delivery tube assembly for an applicator |
| US7527614B2 (en) | 2005-03-25 | 2009-05-05 | Kimberly-Clark Worldwide, Inc. | Protective tube for a medicated tampon |
| US7919453B2 (en) | 2005-03-25 | 2011-04-05 | Kimberly-Clark Worldwide, Inc. | Dosage cap assembly for an applicator |
| US9295289B2 (en) * | 2005-04-01 | 2016-03-29 | Leslie Jane James | Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment |
| US7708726B2 (en) | 2005-04-28 | 2010-05-04 | Kimberly-Clark Worldwide, Inc. | Dosage form cap for an applicator |
| US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| JP5265359B2 (ja) | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
| US20070141106A1 (en) * | 2005-10-19 | 2007-06-21 | Bonutti Peter M | Drug eluting implant |
| US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
| US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
| US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
| US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
| US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
| US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
| BRPI0820800B8 (pt) | 2007-12-11 | 2021-06-22 | Massachusetts Inst Technology | dispositivo médico implantável para liberação controlada de droga |
| BRPI0917135A2 (pt) * | 2008-08-09 | 2015-11-10 | Massachusetts Inst Technology | dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica. |
| JP5913095B2 (ja) | 2009-06-26 | 2016-04-27 | タリス バイオメディカル エルエルシー | 植込み型薬物送達装置及びその作製方法 |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| EP2316498A1 (en) * | 2009-10-30 | 2011-05-04 | Unomedical A/S | A medical hollow tube article |
| US8637096B2 (en) | 2009-12-04 | 2014-01-28 | Curtis C. Stojan | Compositions and method for enhancing insulin activity |
| AU2015201123B2 (en) * | 2009-12-17 | 2016-04-21 | Taris Biomedical Llc | Implantable device with intravesical tolerability and methods of treatment |
| SMT202100236T1 (it) * | 2009-12-17 | 2021-05-07 | Taris Biomedical Llc | Dispositivo impiantabile con tollerabilita' intravescicale |
| EP3517101B1 (en) | 2010-08-05 | 2020-07-15 | TARIS Biomedical LLC | Implantable drug delivery devices for genitourinary sites |
| HRP20201931T1 (hr) | 2010-08-05 | 2021-02-05 | Taris Biomedical Llc | Ureteralno stent sredstvo za isporuku lijeka i pribor |
| WO2012048104A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Implantable drug delivery device with bladden retention feature |
| JP5945544B2 (ja) | 2010-10-06 | 2016-07-05 | タリス バイオメディカル エルエルシー | 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法 |
| CA2823783C (en) | 2011-01-10 | 2023-03-21 | Taris Biomedical, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
| CA2825399A1 (en) * | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
| CA2903164C (en) | 2013-03-15 | 2024-06-11 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| JP2016531088A (ja) | 2013-06-17 | 2016-10-06 | アサナ・バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー | ５ｔ４標的化免疫融合分子および方法 |
| DK3035991T3 (da) | 2013-08-19 | 2020-09-21 | Taris Biomedical Llc | Lægemiddelleveringsindretninger med flere enheder |
| US10933170B2 (en) | 2014-05-12 | 2021-03-02 | Taris Biomedical Llc | Drug delivery devices and methods |
| EP4173615A3 (en) | 2014-06-26 | 2023-07-19 | TARIS Biomedical LLC | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| JP6743041B2 (ja) | 2015-03-30 | 2020-08-19 | タリス バイオメディカル エルエルシー | 上部尿路への薬剤の局所的な送達装置及び方法 |
| KR102658706B1 (ko) | 2015-04-23 | 2024-04-17 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 성분을 구비한 약물 전달 장치 및 방법 |
| US11185670B2 (en) | 2016-01-26 | 2021-11-30 | Taris Biomedical Llc | Multi-lumen drug delivery devices |
| WO2021067857A1 (en) | 2019-10-02 | 2021-04-08 | Watershed Medical, Inc. | Device and method for improving retention of a therapy in the bladder |
| US20240082151A1 (en) * | 2019-10-07 | 2024-03-14 | Oak Crest Institute Of Science | Orally implantable drug delivery device |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
| US4309996A (en) * | 1980-04-28 | 1982-01-12 | Alza Corporation | System with microporous releasing diffusor |
| EP0254394A1 (en) * | 1986-06-16 | 1988-01-27 | Alza Corporation | Dosage form for delivering a drug comprising solubility regulating member |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
| US3887699A (en) * | 1969-03-24 | 1975-06-03 | Seymour Yolles | Biodegradable polymeric article for dispensing drugs |
| US4344431A (en) * | 1969-03-24 | 1982-08-17 | University Of Delaware | Polymeric article for dispensing drugs |
| US3993073A (en) * | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
| US3845761A (en) * | 1970-06-02 | 1974-11-05 | Alza Corp | Intrauterine contraceptive anti-fertility device for the management of reproduction |
| US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US3737521A (en) * | 1970-12-09 | 1973-06-05 | Goodrich Co B F | Formulation for sustained release of a biological agent |
| US3760806A (en) * | 1971-01-13 | 1973-09-25 | Alza Corp | Helical osmotic dispenser with non-planar membrane |
| US3760805A (en) * | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
| US3865108A (en) * | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
| US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
| US3938515A (en) * | 1971-12-20 | 1976-02-17 | Alza Corporation | Novel drug permeable wall |
| US3921636A (en) * | 1973-01-15 | 1975-11-25 | Alza Corp | Novel drug delivery device |
| US4177256A (en) * | 1973-04-25 | 1979-12-04 | Alza Corporation | Osmotic bursting drug delivery device |
| US4351337A (en) * | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
| US3993072A (en) * | 1974-08-28 | 1976-11-23 | Alza Corporation | Microporous drug delivery device |
| US3946734A (en) * | 1975-02-19 | 1976-03-30 | The United States Of America As Represented By The Secretary Of State | Apparatus for controlling the release of a drug |
| US4055178A (en) * | 1976-03-10 | 1977-10-25 | Harrigan Roy Major | Drug delivery device for preventing contact of undissolved drug with the stomach lining |
| US4186745A (en) * | 1976-07-30 | 1980-02-05 | Kauzlarich James J | Porous catheters |
| US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
| US4220152A (en) * | 1978-05-08 | 1980-09-02 | Pfizer Inc. | Delivery system |
| US4304232A (en) * | 1979-03-14 | 1981-12-08 | Alza Corporation | Unit system having multiplicity of means for dispensing useful agent |
| US4402695A (en) * | 1980-01-21 | 1983-09-06 | Alza Corporation | Device for delivering agent in vagina |
| US4455144A (en) * | 1980-12-04 | 1984-06-19 | Alza Corporation | Dispenser constructed with semipermeable polymer-hydrophilic polymer wall |
| US4484921A (en) * | 1982-02-01 | 1984-11-27 | Alza Corporation | Theophylline therapy utilizing osmotic delivery |
| DE3360633D1 (en) * | 1982-02-12 | 1985-10-03 | Unitika Ltd | Anti-cancer device |
| US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
| DE3214667C2 (de) * | 1982-04-21 | 1985-07-18 | Akzo Gmbh, 5600 Wuppertal | Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen |
| FR2559780B1 (fr) * | 1984-02-21 | 1990-05-04 | Tech Cuir Centre | Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs |
| US4619913A (en) * | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
| EP0239039A3 (en) * | 1986-03-24 | 1989-06-07 | Syntex (U.S.A.) Inc. | Intraruminal controlled release device |
-
1987
- 1987-04-30 US US07/057,298 patent/US4871542A/en not_active Expired - Lifetime
-
1988
- 1988-12-08 IN IN875/MAS/88A patent/IN168149B/en unknown
- 1988-12-08 EP EP88311645A patent/EP0372137A1/en not_active Withdrawn
- 1988-12-14 AU AU26850/88A patent/AU622877B2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
| US4309996A (en) * | 1980-04-28 | 1982-01-12 | Alza Corporation | System with microporous releasing diffusor |
| EP0254394A1 (en) * | 1986-06-16 | 1988-01-27 | Alza Corporation | Dosage form for delivering a drug comprising solubility regulating member |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0372137A1 (en) | 1990-06-13 |
| IN168149B (en, 2012) | 1991-02-09 |
| AU2685088A (en) | 1990-08-02 |
| US4871542A (en) | 1989-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU622877B2 (en) | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract | |
| US6171298B1 (en) | Intravesical infuser | |
| US6183461B1 (en) | Method for delivering a medication | |
| JP6854210B2 (ja) | 膀胱内における耐容性を備えた植込み型装置及び治療方法 | |
| US6200257B1 (en) | Catheter with permeable hydrogel membrane | |
| ES2817838T3 (es) | Dispositivos de administración de fármacos de unidades múltiples | |
| ES2441396T3 (es) | Implante para diálisis | |
| US5007897A (en) | Drug delivery catheter | |
| RU2759868C2 (ru) | Устройства и способы для доставки лекарственного средства in vivo | |
| US10406335B2 (en) | Drug delivery systems and methods for treatment of prostate | |
| US20100003297A1 (en) | Implantable Drug Delivery Device and Methods of Treating Male Genitourinary and Surrounding Tissues | |
| JPH05502215A (ja) | ヒドロゲル駆動要素を含む口腔浸透デバイス | |
| JP2013504584A (ja) | 薬物を制御送達するための植込み型装置 | |
| JPH0229268A (ja) | 薬剤徐放のための胃内停滞システム | |
| CN111447965A (zh) | 与导尿管一起使用的药物递送装置和方法 | |
| JP2017500171A (ja) | 浸透圧薬物送達デバイス、キット、及び方法 | |
| US3796217A (en) | Drug release system | |
| PT1294356E (pt) | Sistemas de distribuição de libertação sustentada para solutos | |
| JP6743041B2 (ja) | 上部尿路への薬剤の局所的な送達装置及び方法 | |
| NZ227243A (en) | Floatable device for insertion into the bladder or urinary tract comprising a porous polymeric container and a medicament | |
| JPH02185264A (ja) | 膀胱内又は尿管へ薬を送り込む方法及び装置 | |
| RU2190412C2 (ru) | Способ детоксикации организма | |
| WO2000064513A1 (en) | Pressure responsive valve for use with an intravesical infuser | |
| HK40042011A (en) | Drug delivery systems and methods for treatment of prostate | |
| EP2424462B1 (en) | An adjustable shape changeable surgical implant system |